Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roupret

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC)Y Neuzillet, T Seisen, O Traxer, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Treatment of infiltrating nonmetastatic bladder cancers in elderly patients]H Quintens, L Guy, C Mazerolles, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 19, 2016
[Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment]Y Neuzillet, P Colin, E Comperat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 8, 2015
[Molecular, preclinical, and clinical comparative data regarding different strains of bacillus Calmette-Guérin (BCG): Review by the French Urological Association Oncology Committee (CCAFU)]Y Neuzillet, F Dubosq, E Xylinas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 13, 2022
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer]P Leon, F Saint, F Audenet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 11, 2021
[Urothelial carcinoma in kidney transplant recipients and candidates: The French guidelines from CTAFU]R Boissier, R Thuret, T Prudhomme, et al.
Der Urologe. Ausg. A|February 9, 2021
[COVID-19 in european urology : Which lessons have we learned?]J J Rassweiler, G Pini, F Liatsikos, et al.
Journal of Medical Genetics|July 6, 2004
Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinomaM Roupret, J Catto, F Coulet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations Onco-Urology 2010: Urothelial tumors]C Pfister, M Roupret, H Wallerand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]L Nison, P Colin, M Remzi, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC)Y Neuzillet, T Seisen, O Traxer, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Treatment of infiltrating nonmetastatic bladder cancers in elderly patients]H Quintens, L Guy, C Mazerolles, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 19, 2016
[Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment]Y Neuzillet, P Colin, E Comperat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 8, 2015
[Molecular, preclinical, and clinical comparative data regarding different strains of bacillus Calmette-Guérin (BCG): Review by the French Urological Association Oncology Committee (CCAFU)]Y Neuzillet, F Dubosq, E Xylinas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 13, 2022
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer]P Leon, F Saint, F Audenet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 11, 2021
[Urothelial carcinoma in kidney transplant recipients and candidates: The French guidelines from CTAFU]R Boissier, R Thuret, T Prudhomme, et al.
Der Urologe. Ausg. A|February 9, 2021
[COVID-19 in european urology : Which lessons have we learned?]J J Rassweiler, G Pini, F Liatsikos, et al.
Journal of Medical Genetics|July 6, 2004
Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinomaM Roupret, J Catto, F Coulet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations Onco-Urology 2010: Urothelial tumors]C Pfister, M Roupret, H Wallerand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]L Nison, P Colin, M Remzi, et al.
Pageof 6